Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

KYTX holding history

Kyverna Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYTX overview All 13F holders of KYTX Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2024

Holdings of KYTX by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−119,900−100.0%	Sold out	Holders
Q3 2024	119,900	$586.3K	0.1%	−80,100−40.1%	Reduced	Holders
Q2 2024	200,000	$1.50M	0.2%	+200,000	New	Holders